Adenovirus-mediated ribonucleotide reductase R1 gene therapy of human colon adenocarcinoma.
نویسندگان
چکیده
Ribonucleotide reductase is the enzyme responsible for the reduction of ribonucleotides to their corresponding deoxyribonucleotides for DNA synthesis. Ribonucleotide reductase is a multisubunit complex containing two polypeptides, R1 and R2. In addition to catalytic and allosteric regulatory functions, the R1 subunit appears to act as a novel tumor suppressor. Previous studies demonstrated that overexpression of mouse R1 resulted in suppression of tumorigenicity and metastatic potential, whereas expression of antisense RNA, complementary to R1 mRNA, increased anchorage-independent growth of ras-transformed NIH 3T3 cells. The current study investigated the potential of R1 gene therapy for human cancer using a recombinant adenovirus encoding the human R1 gene (rAd5-R1). Recombinant viruses were constructed by FLP-mediated site-specific recombination and demonstrated high infectivity of a human colon carcinoma cell line (Colo320 HRS), as assessed by expression of a viral encoded beta-Gal gene (rAd5-LacZ). R1mRNA and protein were overexpressed in Colo320 HRS cells infected with rAd5-R1 compared with untreated or rAd5-LacZ-infected cells. Infection with rAd5-R1 inhibited Colo320 HRS cell proliferation, in vitro, in a time- and dose-dependent manner. When Colo320 HRS cells were treated with rAd5-R1, before injection into CD-1 mice, there was complete inhibition of tumor growth compared with treatment with rAd5-LacZ. Furthermore, intratumoral injection of rAd5-R1 into Colo320 HRS tumor xenografts inhibited tumor growth in CD-1 mice compared with rAd5-LacZ treated mice (P = 0.0001). These results demonstrate gene-specific antitumor effects of R1 and suggest that rAd5-R1 gene therapy has the potential to improve currently available treatments for colon cancer.
منابع مشابه
Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells.
Resistance to cytotoxic nucleoside analogues is a major problem in cancer treatment. The cellular mechanisms involved in this phenomenon have been studied for several years, and some factors have been identified. However, this resistance seems to be multifactorial and more studies are needed to gain better insight into this domain. For this purpose, we developed a gemcitabine-resistant cell lin...
متن کاملRibonucleotide Reductase Subunit One as Gene Therapy Target
RNR catalyzes the reaction in which 2 -deoxyribonucleotides are generated from the corresponding ribonucleotide 5 diphosphates. This is the rate-limiting step in the production of 2 -deoxyribonucleoside 5 -triphosphates required for DNA replication. RNR consists of two protein subunits, R1 and R2. The R1 subunit is a Mr 160 KD homodimer that contains the catalytic site, two allosteric effector-...
متن کاملThe Biology Behind Ribonucleotide Reductase Subunit One as Gene Therapy Target
RNR catalyzes the reaction in which 2 -deoxyribonucleotides are generated from the corresponding ribonucleotide 5 diphosphates. This is the rate-limiting step in the production of 2 -deoxyribonucleoside 5 -triphosphates required for DNA replication. RNR consists of two protein subunits, R1 and R2. The R1 subunit is a Mr 160 KD homodimer that contains the catalytic site, two allosteric effector-...
متن کاملInducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette.
We have constructed two new adenovirus expression cassettes that expand both the range of genes which can be expressed with adenovirus vectors (AdV) and the range of cells in which high-level expression can be attained. By inclusion of a tetracycline-regulated promoter in the transfer vector pAdTR5, it is now possible to generate recombinant adenoviruses expressing proteins that are either cyto...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Clinical cancer research : an official journal of the American Association for Cancer Research
دوره 9 12 شماره
صفحات -
تاریخ انتشار 2003